Alkermes plc (ALKS) vs Cytokinetics, Incorporated (CYTK)

A side-by-side comparison of Alkermes plc and Cytokinetics, Incorporated across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ALKS vs CYTK

growth of $100 · dividends reinvested · last 10y
ALKS -7.3% (-0.8%/yr)CYTK +570.6% (+21.0%/yr)CYTK compounded faster over this window
Log scale — wide-divergence pair
101001k10kStart $10020182020202220242026$93$671
ALKS CYTK

ALKS vs CYTK: by the numbers

  • •CYTK is the larger company ($7.73B vs $7.15B market cap).
  • •ALKS is profitable (3.97% net margin) while CYTK runs a net loss (-1259.87%).
  • •ALKS grew revenue faster over the past five years (8.68% vs 4.19% CAGR).

Metrics side by side

Valuation

MetricALKSCYTK
P/E ratio111.33N/A
P/S ratio4.29108.90
P/B ratio3.96N/A
EV / EBITDA45.91N/A
FCF yield3.10%N/A

Profitability

MetricALKSCYTK
Gross margin84.56%84.97%
Operating margin17.21%-695.44%
Net margin3.97%-1259.87%
ROE3.66%N/A
ROIC2.12%-39.80%

Growth (annualized)

MetricALKSCYTK
Revenue CAGR (5Y)8.68%4.19%
FCF CAGR (5Y)20.00%N/A
Total return CAGR (5Y)6.73%11.24%

Frequently asked

Which has grown faster, ALKS or CYTK?
Over the past five years, ALKS grew revenue faster — ALKS at a 8.68% CAGR versus CYTK at 4.19%.
Is ALKS or CYTK more profitable?
ALKS runs the higher net margin — ALKS at 3.97% versus CYTK at -1259.87%.
How have ALKS and CYTK total returns compared?
Over the past 10 years, ALKS delivered -0.82% and CYTK delivered 20.95% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.